Cooperative Agreement UG3HL152373

This $631,589 Project Grant award from the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) will examine the implementation, effectiveness, and cost-effectiveness of two strategies for integrating a community health worker-facilitated hypertension telehealth intervention into primary health centers in Kenya. The goal is to address multi-level barriers to effective hypertension treatment and management. The two implementation approaches are:...

This federal Project Grant award of $130,065 was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to conduct systematic economic analyses on the costs associated with implementing a chronic care model for patients with hypertension. The grant supports a study led by principal investigator Dr. Elaine Khoong and collaborators Dr. Dhruv Kazi, Dr. Lina Tieu, and Dr. Lisa Ochoa-Frongia. The project aims to...

This Project Grant award of $623,433 was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to Oregon Health & Science University (OHSU). The purpose of the grant is to adapt and implement Community Vital Signs (CVS) strategies to increase rates of blood pressure screening and connections to care for hypertension in Nigeria. The key products/services to be delivered through this 4-year project include: 1) Engaging...

This Project Grant award from the National Heart Lung and Blood Institute, under the Cardiovascular Diseases Research program (CFDA 93.837), provides $793,184 to Northwestern University to conduct a 2x2 factorial randomized controlled trial. The trial will evaluate the effects of 1) automated transmission of home blood pressure values versus manual transmission, and 2) automatically-generated medical advice to patients via their patient portal versus no automated feedback. The primary outcome is...

This $285,195 project grant was awarded on August 20, 2025 by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc. to support research on improving hypertension management through patient self-titration of antihypertensive medications. The project aims to adapt this intervention to the U.S. primary care context by assessing patient preferences, provider perspectives, and integration with electronic health records and...

The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research CFDA program (93.837), awarded a $661,129 project grant to Northwestern University to develop and evaluate a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care at Federally Qualified Health Centers. The 5-year project, titled "AN ELECTRONIC HEALTH RECORD-BASED STRATEGY TO OPTIMIZE BLOOD PRESSURE AMONG PREGNANCY-CAPABLE ADULTS IN...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,314,024 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to Weill Medical College of Cornell University to implement the "Coaching and Navigation by CHWs through Telehealth for High-Risk Hypertension" (CONNECT-HTN) intervention. The project aims to reduce death and hospitalization due to heart disease or stroke by connecting patients with severe hypertension to primary care resources and providing...

The Project Grant award of $692,846.00 from the National Heart Lung and Blood Institute's Cardiovascular Diseases Research program (CFDA 93.837) will fund the "Better Heart Study" at the University of Pennsylvania. The study aims to utilize behavioral science strategies to increase hypertension diagnosis and treatment in India, where hypertension prevalence remains high and many individuals are undiagnosed or not receiving care. The project will test two scalable behavioral...

This Project Grant award, valued at $194,722.00, is funded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to support the "Guideline-Recommended Implementation of Pediatric Ambulatory Blood Pressure Monitoring (GRIP ABPM)" project led by Dr. James T. Nugent at Yale University. The objective of this research is to develop and test a multilevel implementation strategy to improve the guideline-recommended use of ambulatory blood pressure...

This Project Grant award from the U.S. Department of Health and Human Services' National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $1,072,621 to Duke University to conduct an adequately powered randomized controlled trial of a multi-component lifestyle intervention aimed at improving blood pressure control and cardiovascular outcomes in Black adults with chronic kidney disease (CKD). The goal is to evaluate the impact of lifestyle modifications,...